Sarepta Therapeutics (SRPT) Return on Capital Employed Growth (1y) (2013 - 2026)
Sarepta Therapeutics (SRPT) Return on Capital Employed Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,805.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 19,453.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -3,457.00 |
| 10 | Sarepta Therapeutics | 1.69 Bn | 1.28 Bn | 622.04 Mn | 229.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 229.00 |
| Dec 31, 2025 | -3,723.00 |
| Sep 30, 2025 | -763.00 |
| Jun 30, 2025 | -148.00 |
| Mar 31, 2025 | -17.00 |
| Dec 31, 2024 | 1,772.00 |
| Sep 30, 2024 | 1,785.00 |
| Jun 30, 2024 | 2,109.00 |
| Mar 31, 2024 | 1,937.00 |
| Dec 31, 2023 | 1,068.00 |
| Sep 30, 2023 | 666.00 |
| Jun 30, 2023 | -199.00 |
| Mar 31, 2023 | -806.00 |
| Dec 31, 2022 | -251.00 |
| Sep 30, 2022 | 81.00 |
| Jun 30, 2022 | 917.00 |
| Mar 31, 2022 | 891.00 |
| Dec 31, 2021 | 413.00 |
| Sep 30, 2021 | 297.00 |
| Jun 30, 2021 | -300.00 |